Minerva Surgical Names Industry Veteran Darin Hammers as New CEO

Minerva Surgical, a commercial-stage medical technology company specializing in minimally invasive solutions for women's uterine health, has announced the appointment of Darin Hammers as its new President, Chief Executive Officer, and Member of the Board of Directors. This strategic move aims to leverage Hammers' extensive experience in the medical device industry to drive the company's growth and innovation in the gynecology space.

With a career spanning three decades, Hammers brings a wealth of expertise to Minerva Surgical. His most recent role was President and CEO of EndoGastric Solutions, which was acquired by Merit Medical. Prior to that, he held leadership positions at DYSIS Medical and Cogentix Medical, the latter of which was acquired by Laborie in 2018. Hammers' experience also includes significant tenure at major medical device companies, including C.R. Bard and Boston Scientific Corporation, where he focused on urology and gynecology divisions.

Dr. Uri Geiger, Chairman of Minerva Surgical, expressed enthusiasm about the appointment, stating, "Mr. Hammers is a dynamic business leader with exceptional strategic capabilities, proven operational effectiveness and strong experience in women's health." This sentiment underscores the company's confidence in Hammers' ability to lead Minerva Surgical through its next phase of growth and development.

Hammers' appointment comes at a crucial time for Minerva Surgical, which has established a broad product line of minimally invasive alternatives to hysterectomy. These solutions are designed to address the most common causes of Abnormal Uterine Bleeding (AUB) across various uterine anatomies. The company's focus on preserving the uterus by avoiding unnecessary hysterectomies aligns with a growing trend in women's health towards less invasive treatment options.

In his new role, Hammers has expressed his commitment to expanding Minerva Surgical's impact in the gynecology sector. "The core portfolio of products is as effective as any on the market when it comes to treating uterine cavity conditions," Hammers stated, "and the goal is to expand our footprint in the gynecology space and become a market leader." This vision suggests a potential for new product development and market expansion under Hammers' leadership.

The appointment of Hammers, with his track record of building high-performing organizations and delivering exceptional results, signals Minerva Surgical's ambition to strengthen its position in the women's health market. His experience in successfully navigating acquisitions and leading companies through periods of growth could prove valuable as Minerva Surgical seeks to expand its influence and product offerings.

As the medical technology industry continues to evolve, particularly in the realm of women's health, Minerva Surgical's decision to bring on a leader with Hammers' experience could position the company to capitalize on emerging opportunities. The focus on minimally invasive solutions aligns with broader healthcare trends towards outpatient procedures and reduced recovery times, potentially offering significant benefits to patients and healthcare providers alike.

Hammers' educational background, including an MBA from Emory University's Goizueta School of Business and a Bachelor of Science in marketing from the University of Southern Indiana, complements his extensive industry experience. This combination of business acumen and sector-specific knowledge could prove instrumental in guiding Minerva Surgical's strategic direction and market positioning.

For more information about Minerva Surgical's innovative medical devices, interested parties can visit https://minervasurgical.com/. As the company enters this new chapter under Hammers' leadership, stakeholders in the women's health sector will likely be watching closely to see how Minerva Surgical evolves and expands its impact on uterine healthcare.